Bay Area's Arcus Biosciences Scores $107M, Initiates Two Clinical Trials Post author:Sam Post published:November 12, 2017 Post category:BioPharma Now totaling $227M, Arcus Biosciences announced it had closed a $107M Series C financing. Source: BioSpace You Might Also Like Ferring Pharma Highlights Progress On Social And Environmental Goals In Corporate Social Responsibility (CSR) Review 2015-2016 April 5, 2017 <b>Flowjo, LLC</b> Launches Cloud Platform For Multi-Omics Experiments May 22, 2017 Bay Area's Adamas Pharma Pays Big Bucks to Double HQ January 21, 2018
Ferring Pharma Highlights Progress On Social And Environmental Goals In Corporate Social Responsibility (CSR) Review 2015-2016 April 5, 2017